Ilex Oncology's P2P Acquisition

Ilex Oncology raised a round of funding on November 16, 2004. Investors include Genzyme.

Ilex brings novel pharmaceutical treatments for cancer patients to market, with its first drug approval in 2001. Building on the successful launch of CamPath and the initiation of clinical trials of c…

Articles about Ilex Oncology's P2P Acquisition: